Biobot Analytics
$13.4M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Biobot Analytics is currently valued at N/A as of June 6, 2025. The company has raised a total of $41.2M in funding.
Investment Perspective
Biobot Analytics's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Biobot Analytics Worth in 2025?
As of 2025, Biobot Analytics is valued at N/A, based on the company's Later Stage VC funding round in June 6, 2025. This valuation positions Biobot Analytics as one of the leading private companies in the sector.
Biobot Analytics Valuation History
Biobot Analytics's funding history demonstrates steady growth and investor confidence.
How Biobot Analytics Valuation is Determined
Private company valuations like Biobot Analytics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Biobot Analytics Valuation FAQs
Is Biobot Analytics profitable?
Biobot Analytics has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Biobot Analytics's valuation compare to competitors?
Biobot Analytics is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Biobot Analytics IPO?
Biobot Analytics has not announced plans for an initial public offering. Until an IPO, investors can access Biobot Analytics shares through secondary market platforms.